Derivatives of the angucycline urdamycin A (1) were prepared in order to study structureactivity relationships in this group of antitumor antibiotics. Derivatives of 1 formed by methanolysis, O-acylation, hydrogenation and treatment with diazomethane were isolated and characterized by their spectroscopic data. Urdamycin G (20) was isolated from Streptomyces fradiae by shortening the fermentation time. The different glycosidation pattern of the aglycone 14 did not lead to significant differences in the biological activity. O-Acylation was shownto enhance the in vitro activity of 1 against stem cells of murine LI210 leukemia depending on the lipophilicity of the molecules. The importance of the 5,6-double bond of 1 with regard to the antitumor activities is discussed. 299 The structure of urdamycin A (1), the main component amongthe angucycline antibiotics produced by Streptomycesfradiae (strain Tii 271 7)1} , was determined from the spectroscopic and chemical data1' 50 , and shown to be in accordance with an X-ray analysis'0. 1 consists of the aglycone aquayamycin (14)4) and three O-glycosidically bonded deoxyhexoses, one^-D-olivose (sugar B) and two a-L-rhodinoses (sugars A and C). Similar compounds with the same aglycone have been found in vineomycin A±5'6\ the saquayamycins7) and the kerriamycins8>9). The structure of urdamycin A (1) is identical to that recently published for kerriamycin B10). 1 is biologically active against Gram-positive bacteria and stem cells of murine L1210 leukemia. In order to investigate the general chemical behavior of 1 under different reaction conditions and to derive structure-activity relationships, various derivatives of 1 were made and characterized. In addition, deolivosylurdamycin A was isolated from S. fradiae as a biosynthetic precursor of 1.
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Methanolysis
Besides the aglycone 14 derhodinosylurdamycin A (17) was obtained by methanolysis of 1 with dichloroacetic acid. The passage of the reaction was observed by HPLCanalysis. 17 was the only intermediate detectable during the conversion of 1 to 14. The lack of resonances of the angular bound rhodinose (sugar C) in the 1H and 13C NMRspectrum strongly suggested structure 17, whose molecular formula was supported by the fast atom bombardment mass spectrum (FAB-MS)with the molecular ion at m/z 730 (negative ion). The CDspectrum of 17 is identical with that of 14 but differs remarkably from that of 1 in the region of 330 nm by the lack of a positive Cotton effect. We explain this by the influence of the angular sugar C on the conformation of rings A and B. Derhodinosylurdamycin A (17) is identical with the previously reported kerriamycin C8~10). Obviously the O-glycosidic bond of sugar Ain 1 is less reactive than that of sugar C but more reactive than that ofsugarB.
Urdamycin G In biosynthetic pathways of oligosaccharide antibiotics the different sugar moieties are connected successively to an aglycone. Thus it might prove possible to obtain urdamycin A variants which may well be important in the biosynthesis by interrupting the fermentation of S. fradiae at various stages. Wewere able to isolate deolivosylurdamycin A as one of the missing links within the urdamycinseries. The new compoundwas called urdamycin Gn).
The fermentation conditions and the work-up procedure of the urdamycins in general have been described elsewhere1}. A modified culture medium with soybean meal 2% and glucose 2% was used. The angucycline production was observed by TLCanalysis. After a fermentation time of 44 hours urdamycin G was isolated as the main product (168 mg/liter) together with lOO mg/liter urdamycin A(l).
The molecular formula C37H46O14of urdamycin G was confirmed by FAB-MS(m/z 714, negative ion). The UVand IR spectra were almost identical with those of 1. By comparison of its NMR data with those of 1 the lack of the olivose moiety (sugar B in 1) was evident. A comparison of the d values and the coupling constants showed that the remaining NMR signals were similar to those of 1. Thus, urdamycin G was assigned the structure 20 and is identical with the recently described OM-4842 (aggreticin)12), which is an inhibitor of platelet aggregation. The isolation of 20 and its yield during the course of the fermentation provide evidence to suggest that the last step during the biosynthesis of 1 is the formation of the glycosidic bond between sugars A and B. Because of this fact and in view of the methanolysis studies described above it is arguable whether kerriamycin C8~10) is a natural product or an artifact caused by the work-up procedure.
O-Acylation
The SB^B^QS'^-penta-O-acetylurdamycin A (2) has already been described1^To prepare acyl derivatives of 1 with varying acyl group positions, 1 was treated with acetic and octanoic anhydride, respectively, in the presence of pyridine, sodium acetate and 4-dimethylaminopyridine. 2 was additionally subjected to a basic cleavage.
The number and the position of O-acyl groups within the isolated acetates and octanoates could be assigned by XHNMRspectroscopy, because of the significant down field shift of the adjacent methine protons caused by the anisotropic effect of the acyloxy groups. The characteristic methine coupling patterns enabled us to initially assign these methine protons to the various individual sugars with the exception of 4B-H and 5'-H, because they have identical coupling constants (/=9.9 Hz). This uncertainty was clarified by 1H-1H correlated two-dimensional NMRspectroscopy (COSY). The results for the sugar moieties of different acyl derivatives are given in Table 1 . The acylation of the phenolic hydroxy group could be seen by the lack of the down field signal of 1 (6 12.38) and by a change of the chemical shift of 10-H/l 1-H. The reaction of 1 with a mixture of acetic anhydride -pyridine (2 : 1) for 8 hours at room tempera- ture yielded 2 (98%). By shortening the treatment to 7 hours, the less lipophilic SB^B^^-tetra-Oacetylurdamycin A (3, 6%) was isolated, in addition to 2 (92%). Application of sodium acetate as catalyst to a solution of 1 in acetic anhydride for 2 hours yielded 3B-0-acetylurdamycin A (4, 53 %), and, after 10 hours, a second product, characterized as 3B,4B-di-0-acetylurdamycin A (5, 18 %). The basic cleavage of 2 was carried out in methanol -water (10 : 7) , saturated with sodium carbonate, at room temperature. After 10 minutes SB^B^'^C-tetra-Oacetylurdamycin A (6, 35%) was found to be the main product besides 5',4C-di-0-acetylurdamycin A (7, 12%). As expected, the basic cleavage enabled us to synthesize regio-isomeric acetates. The sequence of acetylation and deacetylation is disturbed at the phenolic position. 8-OH has only a weak reactivity, but the acetylated phenolic ester is easily cleaved. By treating a solution of 1 in CHC13with a mixture containing octanoic anhydride -pyridine (2 : 1) for 6 hours, a number of products could be detected by TLC. Arranged in order of their increasing yield and lipophilic character, three products, 4B-0-octanoyl-(8, 14%), 3B-0-octanoyl-(9, 21 %) and 3B,4B-di-0-octanoylurdamycin A (10, 26 %) were isolated. SB^B^'^C-Tetra-O-octanoylurdamycin A (12) was obtained as the main product (47%) by stirring a chloroform solution of 1, octanoic anhydride and 4-dimethylaminopyridine (DMAP) for 24 hours, besides 3B,4B,4C-tri-O-octanoylurdamycin A (ll, 14%) as one of several products visible by TLC. Comparing the XHNMRdata of ll and 12 with those of 1, the striking chemical shift of 4'-H and 5A-H is quite interesting. The down field shift of 4'-H about 0.3 ppm is caused by the anisotropic effect of the ester carbonyl group. This effect is not as strong as that detected for the directly adjacent 5'-H (1.7 ppm). The same effect was observed on 6'-H which may tentatively explained by a cis orientation of the acyloxy group with respect to the vicinal hydrogen atom. A similar phenomenon could also be observed for 3B-H, 4B-H and 5B-H in 8, 9 and 10 as well as in the acetates, and provides proof of the assignment of the acylated positions. The up field shift of 5A-H of about 0.2 ppm, which could be detected in the acetates too, is obviously induced by the aliphatic residue of the acyloxy group at C-5'. The orientation of this residue and sugar A should be responsible for this remarkable through space induced shift. In the case of 12 all assignments of NMRsignals were confirmed by^cn-heteronuclear shift correlation (HETCOR).
Assuming acylation under kinetic control, the nucleophilicity of the hydroxy groups in 1 could be assigned directly from the yields of the various acyl derivatives formed under the specified conditions. Twodifferent nucleophilicity sequences depending on the acylating agent used were found. Reaction with Diazomethane After treatment of 1 with diazomethane at 0°C in tetrahydrofuran, two new products, one yellow and one red, could be detected by TLC. Purification of the former failed, because it was easily transformed into the red one during further chromatography on silica gel. The elemental analysis of the red product was in agreement with the molecular formula C44H58N2O17, which was confirmed by FAB-MS(m/z 886, negative ion). Thus, one equivalent diazomethane had added to urdamycin A (1). Comparing the XH NMRspectra of 1 and of the red product, the lack of the olefinic 6-H/5-H resonances suggested that a cycloaddition of diazomethane at the 5,6-double bond resulted in the adduct 24. The observed NH-doublet at 8 6.58 pointed to a tautomerism between the yellow intermediate 24 and its red, more stable tautomer 25. This assumed regioselectivity in the addition of diazomethane was also suggested by the UVdata. There is a bathochromic shift of the long-wavelength absorption band (MeOH: 426 nm in 1, 451 nm in 25, MeOH-NaOH: 580nm in 1, 589 nm in 25) whose explanation seems to require an extended conjugated system including one nitrogen. This 1,3-dipolar cycloaddition, leading to the compounds 24 and 25, is well understood with the help of the valence orbital theory13>14). The 5,6-double bond is electron deficient and conjugated with the quinone system. The cycloaddition proved to be diastereoselective because there is no doubling of signals in the lH NMRspectrum of 24 and 25. The absolute configuration of C-5 in 25 remains unsettled. Biological Activities and Discussion The biological activity of 1 and 14 have already been described15. A number of derivatives described above, were tested against LI210, A 549 and HT29 tumor cells with the stem cell or the proliferation assay (MTT-reduction)15 '16) . In the case of interest, the activity against L1210 tumor cells using the stem cell assay (1 hour experiment) were also tested ( Table 2 ). The comparison of activity between 1, 14, 17 and 20 indicated the relative insignificance of the number of sugar moieties attached to the aglycone. The acyl derivatives showed an increasing biological activity in relation to their increasing lipophilic character; 2, 8 and 21 were the most active derivatives. A further acylation led to the break down of activity. This could be demonstrated in the case of ll and 12. Despite the large numberof acyl derivatives synthesized, no structure-activity relationships with respect to the hydroxy groups could be found. The data for 8 and 9 provide evidence that the acylation of 4B-OHis slightly more effective than acylation of 3B-OH.Methylation of 8-OHled to a decrease, whereas its acetylation led to an increase of antitumor activity, pointing out the necessity of the phenolic hydroxy group, which may be liberated from esters by esterases in the cells. The diacetate 15 of the aglycone aquaya-mycin is similarly active like the pentaacetate 2 of urdamycin A, indicating again that the 0-glycosidically bound sugar moieties are not necessary to induce a basic activity within the angucycline group. Loss of the 5,6-double bond led to a breakdown of the biological activity (22 and 25) and might be explained by the different conformation of rings A and B in 22 and 25 in comparison with 1. It also may be that the vinylogous 5,6-double bond with its reactivity towards nucleophiles is the most important structural element for preservation of cytotoxicity. Derhodinosylurdamycin A (17) 260 [A ofdichloroacetic acid were added to a solution of 133 mg1 in 133 ml MeOHat 4°C. After 72 hours the mixture was neutralized with 2 mNaOHand evaporated to dryness. The crude residue was desalted by dissolving in CHC13and filtered. The residue was chromatographed on a Sephadex LH-20 column (2.5 x 100 cm, MeOH)to yield 95 mg (83 %) derhodinosylurdamycin A (17) and 14 mg (17 %) urdamycinone A (14) . 14 was shown to be identical with the previous described aquayamycin4) in all physico-chemical properties. 
Exp erimental

Urdamycin G (20)
The urdamycin G producing organism S. fradiae (strain Tii 2717) was cultured for 44 hours at 28°C in a medium consisting of soybean meal 2%, glucose 2%, 150 ml in 1-liter Erlenmeyer flasks. The pH was adjusted to 7.2 before autoclaving.
The ethyl acetate extract of the culture filtrate was combined with the acetone extract of the mycelium. The organic solvents were removedunder vacuumand the aqueous residue dissolved in methanol and extracted twice with «-hexane. The methanol layer was evaporated to dryness and chromatogra- Penta-0-acetylurdamycin A (2) 90mg of 1 were dissolved in a mixture of 15 ml acetic anhydride and 7.5 ml pyridine. After stirring for 8 hours at room temperature the solution was poured into ice-water. After 5 hours it was extracted 3 times with CHC13and evaporated to dryness. Pyridine residues were removed by dissolving several times in toluene and evaporating. The residue was chromatographed on a silica gel column (30 x 2 cm, CHC13-MeOH,100 : 2), the main fraction was rechromatographed on Sephadex LH-20 column (100x2.5 cm, MeOH)to yield 110 mg (98%) 2 as a yellow powder, which was shown to be identical with the previously described 21} in all physico-chemical properties.
3B,4B,5/,8-Tetra-O-acetylurdamycin A (3) 123 mg of 1 was treated as described in the last section, but it was poured into ice-water after 7 hours. The same work up procedure yielded 148 mg (92%) of2 and ll mg (6%) of 3: MP160°C; 9: 1) ; IR (KBr) cm "1 3450, 2980, 2938, 2870, 1781, 1745, 1664, 1632, 1598, 1561 ; UV^max nm (e) (MeOH and MeOH-HC1) 360 (4, 770) , 313 (5,500), 258 (15, 300) ; (MeOHNaOH) 401 (3, 100) , 316 (7,700), 255 (12,600) , 224 (17,000); *H NMR (200 MHz, CDC13) To a solution of 36mgof 1 in 10 ml acetic anhydride was added 20mgof sodium acetate and stirred for 2 hours. The mixture was poured into ice-water, extracted 4 times with CHC13and evaporated to dryness. The residue was chromatographed on silica gel column (50 x2 cm, CH2C12-EtOH, 9 : 1). The main fraction was evaporated and purified on a Sephadex LH-20 column (100x2.5 cm, MeOH) to yield 20mg (53%) of4: MP 178°C; Rf0.31 (CHC13 -MeOH, 9:1); IR (KBr) cm "1 3430, 2980 , 2935 , 1727 , 1660 (sh), 1640 , 1621 , 1565 XH NMR (200MHz, CDC13) 3B,4B-Di-0-acetylurdamycin A (5) A mixture of 50 mgof 1, 20 mgsodium acetate and 15 ml acetic anhydride was stirred for 16 hours. It was poured into ice-water, extracted with 3 times with CHC13and evaporated to dryness. The residue was chromatographed on a silica gel column (30x2 cm, CH2C12-EtOH, 95 :5). The two main products were purified on a Sephadex LH-20 column (100 x2.5 cm, MeOH)to yield 10 mg (18%) , all other resonances are very similar to those found for 1. Basic Cleavage 3.5ml of a saturated sodium carbonate solution was added to a solution of 73 mg2 in 10ml MeOHand 7 ml water. After stirring for 10 minutes the reaction was stopped by adding acetic anhydride. It was poured into ice-water, extracted 5 times with CHC13and evaporated to dryness.
The residue was chromatographed on a silica gel column (50x2.5 cm, CH2C12-EtOH, 9: 1). The two main fractions were evaporated and rechromatographed on Sephadex LH-20 column (100 x 2.5 cm, MeOH) to yield 31 mg (35%) of SB^B^'^C-tetra-O-acetylurdamycm A (6) and 10 mg (12%) of 5',4C-di-0-acetylurdamycin A (7). Octanoylation of 1 A): 69 mg of 1 was dissolved in a mixture consist of 2 ml CHC13, 1.5 g octanoic anhydride and 0.76 g pyridine and stirred for 6 hours at room temperature. The solution was poured into ice-water and, after 3 hours, was extracted 3 times with CHC13and evaporated. Pyridine residues were removed by dissolving several times in toluene and evaporating. The remaining orange oil was chromatographed on a silica gel column (40x3 cm, CH2C12-MeOH-triethylamine, 9 : 1 :0.01). Three products were isolated and purified on Sephadex LH-20 column (100x2.5 cm, MeOH) to yield 10.7 mg (13.5 %) of 4B-mono-O-octanoylurdamycin A (8), 16.5 mg (20.8 %) of 3B-mono-0-octanoylurdamycin A (9) and 23.1 mg (25.8 %) of 3B,4B-di-0-octanoylurdamycin A (10). 8: MP 138°C; 9:1) ; IR (KBr) cm "1 3440, 2940 , 2870 , 1730 , 1620 , 1560 lH NMR(200 MHz, CDC13) see Table 1 , , all other resonances are very similar to those found for 10. 6.44 (d, J=10 Hz, 6.92 (d, /=10 Hz, 7.70 (d, /=8 Hz, 7.95 (d, . B): To asolution of 113.7mg of 1 in 5ml CHC13 and 1.85g octanoic anhydride were added 102 mg of DMAP. After 24 hours it was evaporated and the oily residue was treated with ice-water. It was extracted twice with CH2C12, dried and evaporated to yield a yellow oil. Octanoic acid residues were removed by column chromatography on silica gel column (30x3 cm, CH2C12-MeOH-tri- FEB. 1989 ethylamine, 9 : 1 : 0.01). The combined evaporated fractions were rechromatographed on a silica gel column (30 x 3 cm, EtOAc -petroleum ether, 1 : 1). The two main fractions were purified on Sephadex LH-20 column (100 x 2.5 cm, MeOH) to yield 22.7 mg (14.1 %) of 3B,4B,4C-tri-0-octanoylurdamycin A (ll) 4/,5/-Di-O-acetylurdamycinone A (15) A solution containing 76 mg of 14 and 102 mg of DMAPin 12 ml acetic anhydride was stirred for 5 hours. The mixture was poured into ice-water, extracted 3 times with CHC13and evaporated to dryness. The residue was chromatographed on silica gel column (30x3 cm, CH2C12-MeOH, 9 : 1). The main fraction was rechromatographed on a silica gel column (30 x2 cm, CH2C12-MeOH, 9:1) and purified on Sephadex MeOH) 20 mg of sodium acetate were added to 52.3 mg of 17 dissolved in 12 ml acetic anhydride. After stirring for 72 hours the mixture was poured into ice-water, extracted with CHC13and evaporated to dryness. The residue was chromatographed on a silica gel column (30x3 cm, 85 : 15) . The two eluated fractions were purified on Sephadex LH-20 (100x2.5 cm, MeOH)to yield ll.7 mg (21.2%) of 3B-mono-0-acetylderhodinosylurdamycin A (18) and 27.7 mg (47.5%) of 3B,4B-di-Oacetylderhodinosylurdamycin A (19). By using the same work up procedures as described immediately above, 17 mg (65%) of 23 were obtained: MP170°C; Rf 0.47 (CHC13 -MeOH, 9:1); UV^max nm (e) (MeOH and MeOH-HC1) 430 (4,300), 321 (sh, 2,300), 270 (sh, 7,500), 241 (sh, 10,700); (MeOH -NaOH) 548 (4,300), 326 (sh, 3,800) , 281 (8, 200) , 226 (22,500); IR (KBr) cm "1 3430, 1725 , 1660 (sh), 1640 , 1615 XH NMR (200 MHz, acetone-^) d 2.25-2.55 (complex, 5-H2), 3.04-3.15 (complex, 6-H2) , all other resonances are very similar to those found for 17.
Anal Calcd for C37H48O15: C 60.59, H 6.55.
Found: C 60.55, H 6.38.
5,6-Dihydrourdamycinone A (16) 56 mg of 1 were hydrogenated as described in the previous sector. After evaporation, the residue was treated with a mixture H2O, MeOHand trifluoroacetic acid for 10 minutes. It was extracted 3 times with EtOAcand evaporated. The crude residue was chromatographedon a silica gel column (50x 1.5 cm, CH2C12-EtOH, 85 : 15). The main fraction was purified on Sephadex LH-20
